Sven de Vos

Also affiliated with University of California, Los Angeles, Ronald Reagan UCLA Medical Center, Los Angeles Medical Center

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Safety and efficacy of navitoclax, a BCL-2 and BCL-X L inhibitor, in patients with relapsed or refractory lymphoid malignancies: results from a phase 2a study”.

Safety and efficacy of navitoclax, a BCL-2 and BCL-X L inhibitor, in patients with relapsed or refractory lymphoid malignancies: results from a phase 2a study

Leukemia & lymphoma/Leukemia and lymphoma(2020)10.1080/10428194.2020.1845332

N/A

2.2DataRank · unranked

94 citations

John P. Leonard, Jonathan W. Friedberg, Jasmine Zain, Kieron Dunleavy, Rod Humerickhouse +4 more

Phase 1b/2 study of ibrutinib and lenalidomide with dose-adjusted EPOCH-R in patients with relapsed/refractory diffuse large B-cell lymphoma*

Leukemia & lymphoma/Leukemia and lymphoma(2021)10.1080/10428194.2021.1907371

N/A

0.494DataRank · unranked

7 citations

Tycel Phillips, Leslie Popplewell, Sven de Vos, Saurabh Chhabra, Amy Kimball +8 more

Fixed-duration epcoritamab plus R2 drives favorable outcomes in relapsed or refractory follicular lymphoma

Blood(2025)10.1182/blood.2025029909

N/A

0.376DataRank · unranked

9 citations

Anna Sureda, Sirpa Leppä, Joost S.P. Vermaat, Marcel Nijland, Jacob Haaber Christensen +17 more

CD19/CD20 Bispecific Chimeric Antigen Receptor (CAR) in Naive/Memory T Cells for the Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma

Cancer Discovery(2022)10.1158/2159-8290.cd-22-0964

N/A

0DataRank · unranked

102 citations

Christopher M. Walthers, Brenda Ji, Sanaz N. Ghafouri, Jacob Naparstek, Jacqueline Trent +21 more

CD19/CD20 Bispecific Chimeric Antigen Receptor (CAR) in Naïve/Memory T Cells for the Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma

medRxiv(2022)10.1101/2022.09.13.22279873

N/A

0DataRank · unranked

0 citations

Christopher M. Walthers, Brenda Ji, Sanaz N. Ghafouri, Jacob Naparstek, Jacqueline Trent +20 more

Data from CD19/CD20 Bispecific Chimeric Antigen Receptor (CAR) in Naive/Memory T Cells for the Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma

(2023)10.1158/2159-8290.c.6549963

N/A

0DataRank · unranked

0 citations

Christopher M. Walthers, Brenda Ji, Sanaz N. Ghafouri, Jacob Naparstek, Jacqueline Trent +21 more